S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Free A.I. Trade Alerts. Up to 15 opportunities a day. (Ad)
PwC Australia sidelines 9 directors as leak of tax information investigated
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
Free A.I. Trade Alerts. Up to 15 opportunities a day. (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
Free A.I. Trade Alerts. Up to 15 opportunities a day. (Ad)
North Korea notifies neighboring Japan it plans to launch satellite in coming days
Sleepless in Kyiv: Nighttime Russian air campaign terrorizes citizens in Ukrainian capital
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Free A.I. Trade Alerts. Up to 15 opportunities a day. (Ad)
PwC Australia sidelines 9 directors as leak of tax information investigated
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
Free A.I. Trade Alerts. Up to 15 opportunities a day. (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
Free A.I. Trade Alerts. Up to 15 opportunities a day. (Ad)
North Korea notifies neighboring Japan it plans to launch satellite in coming days
Sleepless in Kyiv: Nighttime Russian air campaign terrorizes citizens in Ukrainian capital
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Free A.I. Trade Alerts. Up to 15 opportunities a day. (Ad)
PwC Australia sidelines 9 directors as leak of tax information investigated
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
Free A.I. Trade Alerts. Up to 15 opportunities a day. (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
Free A.I. Trade Alerts. Up to 15 opportunities a day. (Ad)
North Korea notifies neighboring Japan it plans to launch satellite in coming days
Sleepless in Kyiv: Nighttime Russian air campaign terrorizes citizens in Ukrainian capital
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Free A.I. Trade Alerts. Up to 15 opportunities a day. (Ad)
PwC Australia sidelines 9 directors as leak of tax information investigated
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
Free A.I. Trade Alerts. Up to 15 opportunities a day. (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
Free A.I. Trade Alerts. Up to 15 opportunities a day. (Ad)
North Korea notifies neighboring Japan it plans to launch satellite in coming days
Sleepless in Kyiv: Nighttime Russian air campaign terrorizes citizens in Ukrainian capital
NASDAQ:BIOS

BioPlus Acquisition (BIOS) Stock Forecast, Price & News

$10.54
+0.02 (+0.19%)
(As of 05/26/2023 04:00 PM ET)
Compare
Today's Range
$10.53
▼
$10.55
50-Day Range
$10.41
▼
$10.54
52-Week Range
$9.89
▼
$10.55
Volume
81,400 shs
Average Volume
191,855 shs
Market Capitalization
$308.93 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

BIOS stock logo

About BioPlus Acquisition (NASDAQ:BIOS) Stock

BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.

Receive BIOS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioPlus Acquisition and its competitors with MarketBeat's FREE daily newsletter.

BIOS Stock News Headlines

May 26, 2023 | seekingalpha.com
BIOS BioPlus Acquisition Corp.
May 23, 2023 | americanbankingnews.com
BioPlus Acquisition (NASDAQ:BIOS) & Rigetti Computing (NASDAQ:RGTI) Critical Review
May 29, 2023 | Stocks To Trade (Ad)
15 A.I. Trading Opportunities a Day
Using our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.
May 5, 2023 | msn.com
SPAC BIOS to merge with cardiac device maker Avertix
May 3, 2023 | finance.yahoo.com
Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition Corporation
April 27, 2023 | americanbankingnews.com
BioPlus Acquisition Corp. (NASDAQ:BIOS) Short Interest Update
March 18, 2023 | money.usnews.com
BioPlus Acquisition Corp - Ordinary Shares - Class A
September 23, 2022 | wsj.com
BioPlus Acquisition Corp. Cl A
May 29, 2023 | Stocks To Trade (Ad)
3 Free Stock Picks per Day
Using our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.
September 20, 2022 | finance.yahoo.com
BioPlus Acquisition Corp. (BIOS)
September 3, 2022 | investing.com
BioPlus Acquisition Corp (BIOS)
August 13, 2022 | reuters.com
BioPlus Acquisition Corp
August 10, 2022 | finance.yahoo.com
What Type Of Shareholders Own The Most Number of BioPlus Acquisition Corp. (NASDAQ:BIOS) Shares?
See More Headlines
Receive BIOS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioPlus Acquisition and its competitors with MarketBeat's FREE daily newsletter.

BIOS Company Calendar

Today
5/29/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Holding & other investment offices
Sub-Industry
N/A
Sector
Unclassified
Current Symbol
NASDAQ:BIOS
CUSIP
N/A
CIK
1856653
Web
bioplusspac.com
Phone
212-287-4092
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
29,310,000
Free Float
22,686,000
Market Cap
$308.93 million
Optionable
Not Optionable
Beta
0.01

Key Executives

  • Mr. Jonathan M. N. Rigby MBA (Age 55)
    Chairman & Chief Bus. Officer
  • Mr. Ross Haghighat (Age 59)
    CEO, CFO & Director

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions













BIOS Stock - Frequently Asked Questions

How have BIOS shares performed in 2023?

BioPlus Acquisition's stock was trading at $10.22 on January 1st, 2023. Since then, BIOS shares have increased by 3.1% and is now trading at $10.54.
View the best growth stocks for 2023 here.

Are investors shorting BioPlus Acquisition?

BioPlus Acquisition saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 2,500 shares, a drop of 79.3% from the April 30th total of 12,100 shares. Based on an average daily volume of 150,300 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the company's shares are short sold.
View BioPlus Acquisition's Short Interest.

What ETFs hold BioPlus Acquisition's stock?

ETFs with the largest weight of BioPlus Acquisition (NASDAQ:BIOS) stock in their portfolio include Horizon Kinetics SPAC Active ETF (SPAQ), Robinson Alternative Yield Pre-Merger SPAC ETF (SPAX), CrossingBridge Pre-Merger SPAC ETF (SPC) and

When did BioPlus Acquisition IPO?

(BIOS) raised $180 million in an initial public offering on Friday, December 3rd 2021. The company issued 18,000,000 shares at a price of $10.00 per share. Cantor served as the underwriter for the IPO.

What is BioPlus Acquisition's stock symbol?

BioPlus Acquisition trades on the NASDAQ under the ticker symbol "BIOS."

Who are BioPlus Acquisition's major shareholders?

BioPlus Acquisition's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Picton Mahoney Asset Management (3.92%), Boothbay Fund Management LLC (2.67%), First Trust Capital Management L.P. (2.39%), Berkley W R Corp (2.26%), Periscope Capital Inc. (1.63%) and Shaolin Capital Management LLC (1.36%).

How do I buy shares of BioPlus Acquisition?

Shares of BIOS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BioPlus Acquisition's stock price today?

One share of BIOS stock can currently be purchased for approximately $10.54.

How much money does BioPlus Acquisition make?

BioPlus Acquisition (NASDAQ:BIOS) has a market capitalization of $308.93 million.

How can I contact BioPlus Acquisition?

BioPlus Acquisition's mailing address is 260 MADISON AVENUE SUITE 800, NEW YORK NY, 10016. The official website for the company is bioplusspac.com. The company can be reached via phone at 212-287-4092.

This page (NASDAQ:BIOS) was last updated on 5/29/2023 by MarketBeat.com Staff

My Account -